Tue Mar 20, 2018 6:33 pm by mleipold
Hi Santhosh,
If you are using Nat Abund Indium, that's ~96% In115 and ~4% In113. Therefore, you'll have In113 signal at about 4% of your In115 signal.
In the case of a live-dead, you're taking the Dead-neg events forward as Live Intact Singlets. Therefore, your In113 spillover from the In115 would be small (4% of a small number is an even smaller number, and should be background).
One of my current panels has LiveDead on In-natabund (monitor the 115 channel), and CD57 on the In113 channel (from Trace; ~93% In113, ~7% In115 according to the spec sheet). In this case, I actually have a minor but detectable spill from the CD57 into the In115 (Livedead) channel, which shows up as Dead-mid. I've done the backgating (looking at In115 signal on CD57+ and CD57-) to convince myself that things are resolved. Additionally, I still have 0.5-1log separation between the Dead-mid (CD57 spillover) and the Dead+ (genuinely dead), so I don't worry about it.
(I made a big stock of the nat abund Indium DOTA-maleimide years ago, before we got the pure isotopes from Trace....that's why I haven't moved things).
Regarding the Trace Pd stocks: yes, you can use them, particularly with the small-molecule (Zunder-like) BC agents. However, if you make antibody BC (eg, CD45), be sure to look at your spillovers, particularly into the 105 channel...if I recall, the 104 and 106 both have noticeable 105 spills, which can complicate using them with 105. My current BC project is small enough that I'm avoiding the problem by using this 2-of-5 scheme: 89/102/105/108/110
Mike